Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
Latest News
Professor Xin Lu featured in Ludwig's Women in Science report
24 November 2022
Ludwig Oxford student awarded NDM graduate student prize
18 November 2022
Recent publications
-
ASPP2 maintains the integrity of mechanically stressed pseudostratified epithelia during morphogenesis
Journal article
Royer C. et al, (2022), Nature Communications, 13
-
A critique of the hypothesis that CA repeats are primary targets of neuronal MeCP2.
Journal article
Chhatbar K. et al, (2022), Life science alliance, 5
-
Human gastric fibroblasts ameliorate A20-dependent cell survival in co-cultured gastric epithelial cells infected by Helicobacter pylori.
Journal article
Jantaree P. et al, (2022), Biochimica et biophysica acta. Molecular cell research, 1869
Seminars
FOLLOW US
Outreach
Study with us
Work with us
HEALTH INFORMATION
Please refer to the University of Oxford Health page for updated health guidance.